![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5adee5ab4e861a922e9e8eb0fe8e4f3f.svg) | Pepstatin | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5adee5ab4e861a922e9e8eb0fe8e4f3f.svg) | Pepstatin | Ki | 0.01 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_22aa32a5af6ad10865b91bd6cfdcfbf0.svg) | Grassystatin A | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5c819afad8971ba5c8482b5eaa555a1f.svg) | Hydroxyethylamine-based inhibitor 3 | Ki | 63.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5e79065c3d889266bb740dd180a48762.svg) | Statine-like inhibitor A | IC50 | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5e79065c3d889266bb740dd180a48762.svg) | Statine-like inhibitor A | Ki | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_b5e0b3208204b7d87115b4e8005e351b.svg) | Methyl (2S)-1-[(2R)-2-[[(2S)-2-[[(2S,3S)-2-[[(3S,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[(2S)-2-(dimethylamino)-3-phenylpropanoyl]oxypropanoyl]amino]-4-methylpentanoyl]-methylamino]-5-oxopentanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]-3-methylpentanoyl]amino]propanoyl]-methylamino]-3-phenylpropanoyl]pyrrolidine-2-carboxylate | IC50 | 5.5 [1], 50.0 [2], 100.0 [3], 10000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_b1556b0c07451d74f296544a5410f882.svg) | (5Z)-5-[[4-[(4-Benzoyl-3-hydroxy-2-propylphenoxy)methyl]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | IC50 | 210.0 [1], 340.0 [2], 1300.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_75b8610818b3ff57c7d573dfee3e99b3.svg) | 2-Bromo-N-[(2S,3S)-4-[2-(2,4-dichlorophenyl)ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-(3-phenoxyphenyl)butan-2-yl]-4,5-dimethoxybenzamide | IC50 | 0.7 [1], 85.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_75b8610818b3ff57c7d573dfee3e99b3.svg) | 2-Bromo-N-[(2S,3S)-4-[2-(2,4-dichlorophenyl)ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-(3-phenoxyphenyl)butan-2-yl]-4,5-dimethoxybenzamide | Ki | 0.07 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5ba02a6547647871ab54665a73985fbc.svg) | N-[(2S,3R)-4-[[1-(3-Tert-butylphenyl)cyclohexyl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 24.0 [1], 25.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_842dc1dd43300bd8c41b505c4d1ddb38.svg) | 3-(1,1-Dioxothiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-1-phenyl-4-[[3-(trifluoromethyl)phenyl]methylamino]butan-2-yl]benzamide | IC50 | 3570.0 [1], 3900.0 [2], 6760.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_3a6f5d2fa5625bdaea61e36c656fc779.svg) | N-[(2S,3R)-4-(Cyclopropylamino)-3-hydroxy-1-phenylbutan-2-yl]-3-ethyl-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide | IC50 | 7930.0 [1], 7933.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5789f518316bb0bea4739758b5137006.svg) | N-[(2S,3R)-4-[[(2S)-1-(Cyclohexylamino)-1-oxopropan-2-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3-(ethylamino)-5-(2-oxopyrrolidin-1-yl)benzamide | IC50 | 2695.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_219f655f4d82daacfe6925a265702e6e.svg) | Hydroxyethylamine-based inhibitor 2 | IC50 | 320.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_219f655f4d82daacfe6925a265702e6e.svg) | Hydroxyethylamine-based inhibitor 2 | Ki | 320.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_fdab4afdcc40d3a80c4b8f66f84bc1aa.svg) | 3-Ethyl-N-[(2S,3R)-3-hydroxy-1-phenyl-4-[[3-(trifluoromethyl)phenyl]methylamino]butan-2-yl]-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide | IC50 | 1259.0 [1], 1260.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_289446a4045f6ee4080842ca005f7d07.svg) | Methyl (2S)-1-[(2R)-2-[[(2S)-2-[[(2S,3S)-2-[[(3S,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-hydroxypropanoyl]amino]-4-methylpentanoyl]-methylamino]-5-oxopentanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]-3-methylpentanoyl]amino]propanoyl]-methylamino]-3-phenylpropanoyl]pyrrolidine-2-carboxylate | IC50 | 100.0 [1], 2000.0 [2], 5500.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_72401d893025a3f2ec9befb1c4510278.svg) | (4R,4Ar,6R,8aS)-8a-(2,4-difluorophenyl)-4-methyl-6-(3-methyl-1,2-oxazol-5-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine | IC50 | 140.0 [1], 12000.0 [2], 14200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_32b1a99dc47e72aa5a795fd6eb6dda04.svg) | Bace-1 inhibitor | IC50 | 7620.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_32b1a99dc47e72aa5a795fd6eb6dda04.svg) | Bace-1 inhibitor | Ki | 448.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_660bcf78d458eda252978ea31fa54645.svg) | (2e)-2-Imino-3-Methyl-5,5-Diphenylimidazolidin-4-One | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_0d78d629b9d41a432b31079ded962652.svg) | N-[Amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide | IC50 | 60000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_7bc8b337c94be291c036e3ea91d3fa75.svg) | 8,8-Diphenyl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_c8a9c386d28622867f7eb792fb76d4d4.svg) | Statine deriv. 47 | IC50 | 380.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_59d986a96afb35a10453279024147c85.svg) | 2-Amino-4-(4-methoxy-3-methylphenyl)-1-methyl-4-(3-(pyridin-3-yl)phenyl)-1H-imidazol-5(4H)-one | IC50 | 12500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_d17e2bf794bf7aca723d9de98692afe9.svg) | N-Carbamimidoyl-2-[2-(2-Chlorophenyl)-5-[4-(4-Ethanoylphenoxy)phenyl]pyrrol-1-Yl]ethanamide | IC50 | 8200.0 [1], 18900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_ad31b73366faf599885607d5abc5b565.svg) | 2-Amino-4-(biphenyl-3-yl)-1-methyl-4-(pyridin-4-yl)-1H-imidazol-5(4H)-one | IC50 | 30000.0 [1], 30100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_46911b1f18b45f55ddd704e8fbb74a6f.svg) | N-[(2S,3R)-1-(3,5-Difluorophenyl)-3-hydroxy-4-[[1-(3-pyrazol-1-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide | IC50 | 22.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_95a7182ff86051f224227000412ee15d.svg) | 2-Amino-5-[3-(2-fluoropyridin-3-yl)phenyl]-5-(4-methoxy-3-methylphenyl)-3-methylimidazol-4-one | IC50 | 2580.0 [1], 2600.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_173106844a4c28f8cd650c3fff830dd4.svg) | Statine-like inhibitor 16 | Ki | 4.9 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_42d988952b973b63095d7805444d3581.svg) | N-[(2S,3R)-4-[[4-(3-Tert-butylphenyl)oxan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 230.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_f555cc716f4d05f081210f3a56abd4d9.svg) | 3-(Ethylamino)-N-[(2S,3R)-3-hydroxy-1-phenyl-4-[[3-(trifluoromethyl)phenyl]methylamino]butan-2-yl]-5-(2-oxopyrrolidin-1-yl)benzamide | IC50 | 5750.0 [1], 6580.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_ced879b56b7fff140c99f5c214b605cc.svg) | 3,5-Dichloro-2-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]-N-[4-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]phenyl]benzamide | IC50 | 250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_9a7ceb83b7b197b0d1c88e772b19b2ba.svg) | 1-N-[(1R,2S)-3-(3,5-Difluorophenyl)-1-hydroxy-1-[(2R,4R)-4-phenylmethoxypyrrolidin-2-yl]propan-2-yl]-5-methyl-3-N,3-N-dipropylbenzene-1,3-dicarboxamide | Ki | 36.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_18cb4fb4affdbc27dd2fb756ee1ea33a.svg) | 1-N-[(1R,2S)-3-(3,5-Difluorophenyl)-1-hydroxy-1-[(2R,4R)-4-phenoxypyrrolidin-2-yl]propan-2-yl]-5-methyl-3-N,3-N-dipropylbenzene-1,3-dicarboxamide | Ki | 291.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_10e640097aa734b59d97d19ed1451bf6.svg) | 2-[2-(1-Adamantyl)-5-phenylpyrrol-1-yl]-N-[N'-(3-hydroxypropyl)carbamimidoyl]acetamide | IC50 | 19400.0 [1], 19900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_f8902ef79251a0a60858290ea07fa763.svg) | 3-Ethyl-N-[(2S,3R)-3-hydroxy-4-(oxan-4-ylamino)-1-phenylbutan-2-yl]-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide | IC50 | 60.0 [1], 6610.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_be7dd119118bccc881c08ecba297a696.svg) | 2-Amino-7-(4-pentylphenyl)-3-[[(2S,5R)-5-phenyloxolan-2-yl]methyl]quinazolin-4-one | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_dd9823686ca943986bd9606709139317.svg) | 2-Amino-3-[[(2S,5R)-5-phenyloxolan-2-yl]methyl]-7-[4-(3-phenylpropyl)phenyl]quinazolin-4-one | IC50 | 6000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_f321e93f71b3269a4cab83d94a33df5d.svg) | N-[2-(1,3-Benzodioxol-5-yl)ethyl]-N-[(2S,3S)-3-[[2-(2,4-dichlorophenoxy)acetyl]amino]-2-hydroxy-4-phenylbutyl]-3-(1,3-dioxoisoindol-2-yl)propanamide | Ki | 3.0 [1], 9.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_07f63030516e2d81b1a0138df5d6dbb6.svg) | N-[2-(2-Adamantan-1-yl-5-phenyl-pyrrol-1-yl)-acetyl]-guanidine | IC50 | 25000.0 [1], 30200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_6941f85a97da0904b69d539dcd8b3d6a.svg) | (2R,4S,5S)-5-[[(2S)-2-[[(2S)-2-Acetamido-4-methylpentanoyl]amino]propanoyl]amino]-N-butyl-4-hydroxy-2,7-dimethyloctanamide | IC50 | 260.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_8b31e8620a50a5ca8960f3c8aa5bc675.svg) | (2r,4s,5s)-N-Butyl-4-Hydroxy-2,7-Dimethyl-5-{[n-(4-Methylpentanoyl)-L-Methionyl]amino}octanamide | IC50 | 370.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_735dbdbdb300f52dccb0ba198350c31b.svg) | 3-(1,1-Dioxothiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-4-[(6-methoxy-2,3-dihydro-1H-inden-1-yl)amino]-1-phenylbutan-2-yl]benzamide | IC50 | 1070.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_4fdadc165ee471362462b5878bf53be3.svg) | (2R,4S)-N-Butyl-4-[(2S,5S,7R)-2,7-dimethyl-3,16-dioxo-1,4-diazacyclohexadec-5-yl]-4-hydroxy-2-methylbutanamide | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_cb2c4128b47698b975b349352d73d56c.svg) | 3-Ethyl-N-[(2S,3R)-3-hydroxy-1-phenyl-4-(3,3,3-trifluoropropylamino)butan-2-yl]-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide | IC50 | 890.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_75fec5d493b498b5a14d60621888f0b4.svg) | N-[(2S,3S)-1-[[5-(Butylamino)-3-hydroxy-5-oxo-1-phenylpentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-(pyrrolidin-1-ylmethyl)benzamide | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_75fec5d493b498b5a14d60621888f0b4.svg) | N-[(2S,3S)-1-[[5-(Butylamino)-3-hydroxy-5-oxo-1-phenylpentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-(pyrrolidin-1-ylmethyl)benzamide | Ki | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_674953680467e558a83391ffeaaa812d.svg) | N-[1-[[3-Hydroxy-6-methyl-1-oxo-1-(3-phenylpropylamino)heptan-4-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-(methylaminomethyl)benzamide | Ki | 1300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_aec14eee25f508349c6c029651cc95fe.svg) | N-[(2S,3R)-4-[[(2S)-1-(Cyclohexylamino)-1-oxopropan-2-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3-methylsulfonylbenzamide | IC50 | 7700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_31e9464990bf6d178bff4a9ce9f3d1cb.svg) | N-[(2S,3R)-4-[[(2S)-1-(Cyclohexylamino)-1-oxopropan-2-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3-(2-oxopyrrolidin-1-yl)benzamide | IC50 | 25630.0 [1], 26000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_c852937e9e9062fabc3731c4d6e5e283.svg) | N-[(2S,3R)-4-[[1-(3-Tert-butylphenyl)cyclopropyl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 220.0 [1], 290.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_024ad632bd345e1dff4b2f1f8b20e4ab.svg) | N-[(2S,3R)-1-(3,5-Difluorophenyl)-4-[[1-[1-(2,2-dimethylpropyl)pyrazol-4-yl]cyclopropyl]amino]-3-hydroxybutan-2-yl]acetamide | IC50 | 720.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_ede6e6640ad57e6255542bff17c0f882.svg) | N-[(2S,3R)-4-[[1-(6-Tert-butylpyrimidin-4-yl)cyclohexyl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 245.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_cd08068ff56ab984ba5c891955a6c812.svg) | (3S,4S,5R)-3-[[4-Amino-3-fluoro-5-(1,1,1,3,3,3-hexafluoropropan-2-yloxy)phenyl]methyl]-5-[(3-tert-butylphenyl)methylamino]-1,1-dioxothian-4-ol | IC50 | 450.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_0c8902e3e2012689e525023ed6ad8348.svg) | Statine-like inhibitor 24 | Ki | 473.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_b98318260d46edd272616b1342a8fc8b.svg) | Statine-like inhibitor 27 | Ki | 4000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_cbd5e1b4b7f985986a2d0a5bd07a951e.svg) | Statine-like inhibitor 33 | Ki | 5900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_79ba15648b254b9d0c54a18c3d94e46c.svg) | Statine-like inhibitor 34 | Ki | 5900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_05112eb3f07fbabed7d86451cb20e9db.svg) | (2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(prop-2-enoxy)hexanediamide | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_8af6c042a4d2abdbe0383edf73ecd207.svg) | (2R,3R,4R,5R)-2,5-Bis[(E)-3-bromoprop-2-enoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_04879c307ee521296428a0925ede1add.svg) | Methyl (2S)-1-[(2R)-2-[[(2S)-2-[[(2S)-2-[[(3S,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-hydroxypropanoyl]amino]-3-methylbutanoyl]-methylamino]-5-oxopentanoyl]amino]-3-hydroxy-5-phenylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]-methylamino]-3-phenylpropanoyl]pyrrolidine-2-carboxylate | IC50 | 50.0 [1], 182.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_bb5981db7c088dac9179f8273901f63e.svg) | (4Ar,6S,8aS)-8a-(2,4-difluorophenyl)-6-methyl-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine | IC50 | 72000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_5dbb64efbf7b6f1baf081be2640ac145.svg) | 5-[4-(4-Benzoyl-3-hydroxy-2-propyl-benzyloxy)-benzylidene]-2-thioxo-thiazolidin-4-one | IC50 | 210.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_b0a6b2f78980cd0f0f225025f277bb9a.svg) | N-[(2S,3R)-4-(Cyclohexylamino)-3-hydroxy-1-phenylbutan-2-yl]-3-ethyl-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide | IC50 | 660.0 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_56dc874fa2c3efc4bd2ea3ec26414359.svg) | N-[(2S,3R)-4-(2,6-Dimethylheptan-2-ylamino)-3-hydroxy-1-phenylbutan-2-yl]-3-ethyl-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide | IC50 | 660.0 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_92becc97f810a9d74aae1f7a5a7b89ab.svg) | 3-Ethyl-N-[(2S,3R)-3-hydroxy-4-(methylamino)-1-phenylbutan-2-yl]-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide | IC50 | 58880.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_2e45fe52308d00e13733a9a52af9ecb5.svg) | N-[(2S,3R)-4-(Benzylamino)-3-hydroxy-1-phenylbutan-2-yl]-3-(1,1-dioxothiazinan-2-yl)-5-(ethylamino)benzamide | IC50 | 26300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_ad9966e722ccbbf9d3b2a21f8c7cd5fb.svg) | N-[(2S,3R)-4-(Cyclopropylamino)-3-hydroxy-1-phenylbutan-2-yl]-3-(1,1-dioxothiazinan-2-yl)-5-(ethylamino)benzamide | IC50 | 30200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_57acda8c21dd63b0a095119675305b7d.svg) | N-[(2S,3R)-4-[[1-(3-Tert-butylphenyl)-4-hydroxycyclohexyl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 1400.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_6472899f744fa26826e1c558d52d84e0.svg) | N-[(2S,3R)-4-[[(4S)-6-(2,2-Dimethylpropyl)-3'-hydroxyspiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 577.0 [1], 1650.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_627eb5a4b5e29420351708cc784c49ec.svg) | N-[(2S,3R)-4-[[(4S)-6-(2,2-Dimethylpropyl)-3'-methylspiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 8.0 [1], 38.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_3c4dcbeba5dcc2e3a005da83e64df185.svg) | N-[(2S,3R)-4-[[(4S)-6-(2,2-Dimethylpropyl)-3'-fluorospiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 12.0 [1], 22.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_e6a0fe49f38b684057d35a18d90f43da.svg) | N-[(2S,3R)-1-(3,4-Difluorophenyl)-4-[[(4S)-6-(2,2-dimethylpropyl)-3'-methylspiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide | IC50 | 4.0 [1], 17.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_3f2b5de86d4c82df24c9c7ae587b61ef.svg) | N-[(2S,3R)-4-[[(4S)-6-(2,2-Dimethylpropyl)-3'-fluorospiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide | IC50 | 8.0 [1], 14.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_f51c285ab4c4b05b5a79103938f640a5.svg) | Resveratrol | IC50 | 138000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_a8161d240c376d7c9009e0af18efe95d.svg) | Ursolic acid | IC50 | 18200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_37fef5d7ee863b666b84a39f671e4b86.svg) | Amprenavir | IC50 | 15200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_57727bd92c39ba414ca11252c2d4761f.svg) | Nafamostat | IC50 | 1000000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_b1e6e5944b79f1f5a99eb6543bfa114f.svg) | Piperine | IC50 | 42300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_27b2678bd601e84b6ff113fc9266764d.svg) | Tipranavir | Ki | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_e779b99cccc83bda1fe3b6b3793b00ec.svg) | CID 11199915 | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_157369e51d1eb214b450dabd24b89650.svg) | (2S)-1-[(2S,3S)-3-Methyl-2-[[(2S,3S)-3-(propylcarbamoyl)oxirane-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carboxylic acid | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_f981ba72019518b7576b2dce0f0e46d6.svg) | EVNLPsiAAEF | IC50 | 6.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_38f4d151f4e09a03d9b7b3382c611f21.svg) | Verubecestat | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_b503c2b6d51035b4151c401138b75c4e.svg) | (2R,3R,4R,5S)-6-Cyclohexyl-3,4-dihydroxy-5-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-naphthalen-1-yloxyacetyl)amino]propanoyl]amino]-N-[(2S,3S)-3-methyl-1-oxo-1-(pyridin-2-ylmethylamino)pentan-2-yl]-2-propan-2-ylhexanamide | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_83ebacb436659f04a24927924097abe6.svg) | (S)-4-(2,4-Difluoro-5-(pyrimidin-5-yl)phenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine | IC50 | 15700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_6ace68f1f9ffeb30b3f60199676d80f4.svg) | Balicatib | Ki | 1.29 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_c8aa1141ac7cc30e73bcde767ec2a7f0.svg) | Lanabecestat | IC50 | 16100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_d92bdcf900d072b0fd3bd4e6f0a5f4e3.svg) | N1,N6-Di[(1S)-indanyl-(2R)-hydroxy]-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-dihydroxyhexanediamide | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_7fa05ae6b00092352ddc76ed823a4a0d.svg) | Methyl N-[(2S)-1-[[(5S)-5-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-6-hydroxyhexyl]amino]-1-oxo-3,3-diphenylpropan-2-yl]carbamate | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_2da69220e39477ea109cbebfe8c599f7.svg) | CID 66665322 | IC50 | 250000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_2c4478b3e53ecd18d8af35f717c5401a.svg) | beta-Sitosterone | IC50 | 9400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_83ce4e5fb30ce0f4741b16fd9b43a79a.svg) | Unii-1NE31CW68S | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_ad259c8c8b62adb77c52fd8394f50fa2.svg) | Aliskiren hydrochloride | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_9f2d40d63c6bba3420f23c2b199f9970.svg) | Tasiamide B | IC50 | 251.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_b2a940b6a41e71595b44efca6ccd460c.svg) | Unii-114L0XB8FM | Ki | 4300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_06a27b2aeef3c078bbbbeea3d7806189.svg) | CID 118253852 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cathepsin-d_96d50736471b91ec6504f67881d8b3af.svg) | Statine deriv. 50 | IC50 | 1000.0 [1] |